Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Biogen Inc. (BIIB) had Free Cash Flow per Share of $2.43 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.65B |
|
$634.80M |
|
$605.00M |
|
$2.04B |
|
$1.85B |
|
$792.70M |
|
$-48.70M |
|
$744.00M |
|
$744.00M |
|
$634.80M |
|
$634.80M |
|
$634.80M |
|
$634.80M |
|
$792.70M |
|
$1.04B |
|
146.50M |
|
146.70M |
|
$4.33 |
|
$4.33 |
|
| Balance Sheet Financials | |
$7.97B |
|
$3.10B |
|
$20.36B |
|
$28.33B |
|
$3.18B |
|
$6.28B |
|
$7.51B |
|
$10.70B |
|
$17.63B |
|
$1.67B |
|
$17.63B |
|
146.60M |
|
| Cash Flow Statement Financials | |
$420.20M |
|
$-104.30M |
|
$-34.70M |
|
$2.38B |
|
$2.76B |
|
$383.80M |
|
$155.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
0.26 |
|
0.36 |
|
77.13% |
|
29.96% |
|
29.96% |
|
-- |
|
28.12% |
|
24.00% |
|
$356.50M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.27 |
|
1.63 |
|
55.26 |
|
3.60% |
|
37.93% |
|
2.24% |
|
2.65% |
|
$120.29 |
|
|
Free Cash Flow per Share |
$2.43 |
$2.86 |
|